Mitr Clinic team
Accelerating progress toward the end of AIDS in India
The Union Conference 2022
1
2
3
May 11, 2023

June 7: Save the date for an in-person conversation with Simran Bharucha, Director of Transgender Health, Project ACCELERATE.

January 31, 2023

The third largest HIV/AIDS epidemic in the world, more than 2.4 million people in India are living with HIV. 

November 8, 2022

CIDI researchers and faculty will join the virtual Union Conference--check out our agenda!

DEVELOPMENTS NEWS ENGAGE

Dr. Vidya Mave and colleagues concluded considerable intrahost mycobacterium tuberculosis mutation rates were present at recurrence among patients with diabetes mellitus. 

Akshay Gupte

Dr. Akshay Gupte and team found females were 7 times more likely to have restrictive spirometry pattern and 22 times more likely to have preserved ratio impaired spirometry, compared with men.

Mehta and Lucas headshots

The findings by Drs. Shruti Mehta, Gregory Lucas and colleagues show population-specific interventions and routine surveillance are need to facilitate HIV elimination.

Suniti Solomon

Dr. Suniti Solomon detected India’s first cases of HIV. She also founded YRG CARE & raised CIDI Co-director Dr. Sunil Solomon. Learn about her commitment to science & unwavering dedication to compassionate patient care.

Group Photo

World TB Day event in Pune includes a special street play, counseling sessions, and research and education discussions, aimed to  engage the community in healthy approaches to TB treatment and prevention under this year’s World TB Day theme "Yes we can end TB."

Amita Gupta, MD, MHS

The patient courses will include the three-month 3HP regimen, and the even shorter 1HP, that is only taken for 28 days. This contribution is part of the Consortium’s ongoing efforts to end TB and improve global health outcomes. 

Team photo

The launch of the study coincides with the World TB week. “Titled `PraGaTHi’, this study will explore how the changes in immunity due to pregnancy and GDM increase the risk of TB in pregnant and postpartum women.”

Vidya Mave

Dr. Vidya Mave discusses the pros and cons of shortened tuberculosis treatment with bedaquiline, pretomanid, moxifloxacin, and pyrazinamide (BPaMZ).

Accelerating progress toward the end of AIDS in India

The third largest HIV/AIDS epidemic in the world, more than 2.4 million people in India are living with HIV.